Cargando…

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

BACKGROUND: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for therapeutic strategies in multiple myeloma (MM). Here, we e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quwaider, Dalia, Corchete, Luis A., Misiewicz-Krzeminska, Irena, Sarasquete, María E., Pérez, José J., Krzeminski, Patryk, Puig, Noemí, Mateos, María Victoria, García-Sanz, Ramón, Herrero, Ana B., Gutiérrez, Norma C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395780/ https://www.ncbi.nlm.nih.gov/pubmed/28420429 http://dx.doi.org/10.1186/s13045-017-0461-8

Ejemplares similares

Factors Regulating microRNA Expression and Function in Multiple Myeloma
por: Misiewicz-Krzeminska, Irena, et al.
Publicado: (2019)

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma
por: Herrero, Ana B., et al.
Publicado: (2016)

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma
por: Rojas, Elizabeta A., et al.
Publicado: (2022)

FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma
por: Herrero, Ana Belén, et al.
Publicado: (2020)

Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background
por: Rojas, Elizabeta A., et al.
Publicado: (2019)

A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility
por: Misiewicz-Krzeminska, Irena, et al.
Publicado: (2018)

Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines
por: Paíno, Teresa, et al.
Publicado: (2014)

RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
por: Quwaider, Dalia, et al.
Publicado: (2022)

Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future
por: Medina-Herrera, Alejandro, et al.
Publicado: (2023)

P848: EXPRESSION PROFILE OF BCL-2 FAMILY PROTEINS IN MULTIPLE MYELOMA.
por: Sánchez, Cristina De Ramón, et al.
Publicado: (2023)

Extracellular Vesicles in Multiple Myeloma—Cracking the Code to a Better Understanding of the Disease
por: Iskrzak, Justyna, et al.
Publicado: (2022)

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair
por: López-Iglesias, Ana-Alicia, et al.
Publicado: (2017)

Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells
por: Catena, Valeria, et al.
Publicado: (2016)

CRL4(CRBN) E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma
por: Barankiewicz, Joanna, et al.
Publicado: (2022)

Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse
por: Krzeminski, Patryk, et al.
Publicado: (2016)

The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma
por: Hernández-García, Susana, et al.
Publicado: (2017)

MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
por: Rodríguez-Vicente, Ana E, et al.
Publicado: (2015)

DEPTOR in Skeletal Development and Diseases
por: Perez-Tejeiro, Jose Miguel, et al.
Publicado: (2021)

Effect of Graphene Family Materials on Multiple Myeloma and Non-Hodgkin’s Lymphoma Cell Lines
por: Strojny, Barbara, et al.
Publicado: (2020)

Multiple myeloma with t(11;14): impact of novel agents on outcome
por: Puertas, Borja, et al.
Publicado: (2023)

Elucidating the role of DEPTOR in Alzheimer’s disease
por: DAVIES, JULIE, et al.
Publicado: (2014)

Transcriptional signature of TP53 biallelic inactivation identifies a group of multiple myeloma patients without this genetic condition but with dismal outcome
por: De Ramón, Cristina, et al.
Publicado: (2022)

DEPTOR is linked to a TORC1-p21 survival proliferation pathway in multiple myeloma cells
por: Yang, Yonghui, et al.
Publicado: (2014)

Regulatory role of DEPTOR-mediated cellular autophagy and mitochondrial reactive oxygen species in angiogenesis in multiple myeloma
por: Wang, Jizhen, et al.
Publicado: (2021)

Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression
por: Díaz-Tejedor, Andrea, et al.
Publicado: (2021)

Deptor: not only a mTOR inhibitor
por: Catena, Valeria, et al.
Publicado: (2017)

Regulation of human mTOR complexes by DEPTOR
por: Wälchli, Matthias, et al.
Publicado: (2021)

Function of Deptor and its roles in hematological malignancies
por: Morales-Martinez, Mario, et al.
Publicado: (2021)

Placental DEPTOR as a stress sensor during pregnancy
por: Mparmpakas, Dionisis, et al.
Publicado: (2011)

Loss of hepatic DEPTOR alters the metabolic transition to fasting
por: Caron, Alexandre, et al.
Publicado: (2017)

Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205
por: Flis, Sylwia, et al.
Publicado: (2009)

Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation
por: Vega, Mario, et al.
Publicado: (2022)

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial
por: Puig, Noemí, et al.
Publicado: (2020)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020)

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
por: Barankiewicz, Joanna, et al.
Publicado: (2021)

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
por: Medina, Alejandro, et al.
Publicado: (2020)

Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients
por: Muntión, Sandra, et al.
Publicado: (2016)

DEPTOR has growth suppression activity against pancreatic cancer cells
por: Li, Hua, et al.
Publicado: (2014)

Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation
por: Wang, Xuecen, et al.
Publicado: (2022)

DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_580r75kgtudehrvkrgirf8ki7n